IWA
LLY icon

Icon Wealth Advisors’s Eli Lilly LLY Stock Holding History

Icon Wealth Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Buy
9,178
+754
+9% +$770K 0.66% 36
2026
Q1 		$7.17M Sell
8,424
-5,936
-41% -$6.02M 0.47% 44
2025
Q4 		$15.3M Sell
14,360
-203
-1% -$194K 1.02% 26
2025
Q3 		$11.1M Buy
14,563
+430
+3% +$320K 0.75% 33
2025
Q2 		$11M Sell
14,133
-69
-0.5% -$53.6K 0.78% 30
2025
Q1 		$11.7M Buy
14,202
+2,165
+18% +$1.8M 0.96% 24
2024
Q4 		$9.29M Buy
12,037
+2,436
+25% +$2.02M 0.76% 27
2024
Q3 		$8.51M Sell
9,601
-126
-1% -$113K 0.71% 27
2024
Q2 		$7.82M Buy
9,727
+477
+5% +$382K 0.7% 27
2024
Q1 		$7.2M Buy
9,250
+24
+0.3% +$17.1K 0.67% 28
2023
Q4 		$5.38M Buy
+9,226
New +$5.39M 0.56% 33
2022
Q4 		$5.22M Buy
14,270
+37
+0.3% +$13.1K 0.6% 43
2022
Q3 		$4.6M Buy
+14,233
New +$4.51M 0.56% 41

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Icon Wealth Advisors's LLY Position: Q2 2026 in Review

Icon Wealth Advisors increased its Eli Lilly (LLY) stake by 9% in Q2 2026, buying an estimated $770K and bringing the position to 9,178 shares worth $11M. The position accounts for 0.66% of the portfolio, ranked #36.

Icon Wealth Advisors first reported a position in LLY in Q3 2022 and has held it in 13 quarters since. The position peaked at $15.3M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Icon Wealth Advisors held 9,178 shares of Eli Lilly worth $11M as of Q2 2026.
  • Icon Wealth Advisors bought 754 Eli Lilly shares in Q2 2026, an estimated $770K.
  • Eli Lilly made up 0.66% of Icon Wealth Advisors's portfolio in Q2 2026, its #36 holding.
  • Icon Wealth Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 13 quarters since.
  • Icon Wealth Advisors's Eli Lilly position peaked at $15.3M in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Icon Wealth Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.